Rybelsus has emerged as a game-changer in diabetes management, particularly in the approach to timing. This medication, the first oral GLP-1 receptor agonist, requires strategic use to maximize its benefits. Patients and healthcare professionals alike must grasp the nuances of Rybelsus timing mastery, as improper use can lead to suboptimal…